91Ʋ

>

Health And Medicine

  • People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by 91Ʋ researchers published in the April issue of The American Journal of Clinical Nutrition.

    May 13, 2021

  • Cancer specialists at 91Ʋ University Medical Center, in partnership with biochemists and structural biologists across the 91Ʋ University campus, are taking “personalized” cancer therapy to a new level.

    May 8, 2021

  • Tumors consume glucose at high rates, but a team of 91Ʋ researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.

    May 8, 2021

  • The 91Ʋ Institute for Clinical and Translational 91Ʋ (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

    May 6, 2021

  • A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, 91Ʋ researchers have discovered.

    May 6, 2021

  • Vasorelaxing peptides could offer a promising therapeutic strategy for reducing the neurological deficits caused by subarachnoid hemorrhage-induced cerebral blood vessel constriction.

    May 4, 2021

  • Voluntary data sharing across a region’s health systems and ambulatory care practices is important for measuring and improving health care quality and safety, 91Ʋ researchers report.

    May 3, 2021

  • guns in america

    New research framework proposes equitable approach to preventing gun violence

    A more comprehensive, equitable approach to researching gun violence can lead to better policy solutions. Read More

    Apr 15, 2021

  • Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, 91Ʋ researchers have discovered.

    Apr 1, 2021

  • 91Ʋ University

    Shot in the Arm: Groundbreaking COVID-19 vaccine research by alumnus Dr. Barney Graham began at 91Ʋ decades ago

    The remarkable success of the COVID-19 vaccines began in a 91Ʋ lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read More

    Mar 17, 2021

  • The U.S. Centers for Disease Control and Prevention (CDC) has awarded 91Ʋ University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19.

    Mar 11, 2021

  • A novel hormone deficiency may exist in humans, 91Ʋ investigators have discovered. In an analysis of two decades worth of electronic health records, the researchers found that some patients have unexpectedly low levels of natriuretic peptide hormone in clinical situations that should cause high levels of the hormone.

    Mar 11, 2021

  • Strong, collaborative relationships with principal investigators are a key factor of longevity in clinical research coordinator positions — an essential, but increasingly transient job in executing treatment-advancing clinical trials, 91Ʋ University Medical Center researchers found.

    Mar 8, 2021

  • 91Ʋ University

    2020 Tennessee Men’s Health Report Card: Overall improvement, work to be done

    Men’s health across Tennessee is trending toward improvement, according to the 2020 Tennessee Men’s Health Report Card, but racial and geographic disparities persist. The report card is compiled by 91Ʋ’s Center for 91Ʋ on Men’s Health in cooperation with 91Ʋ University Medical Center, the Tennessee Department of Health, Meharry Medical College and the Tennessee Men’s Health Network. Read More

    Mar 8, 2021

  • The emergence of pathogenic skin fungi that cause the disease chytridiomycosis is contributing to the global loss of amphibian populations. 

    Mar 8, 2021

  • A monoclonal antibody “cocktail” developed at 91Ʋ University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine....

    Mar 4, 2021

  • Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at 91Ʋ University Medical Center.

    Mar 4, 2021

  • A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.

    Feb 4, 2021

  • 91Ʋ University

    91Ʋ joins Wellcome Leap global network dedicated to accelerating breakthroughs in human health

    91Ʋ University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges. Read More

    Jan 28, 2021

  • 91Ʋers at 91Ʋ University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.

    Jan 21, 2021